Summarise This Assignment Explained for Students (Easy Guide)

This question focuses on applying theory to practical scenarios.

What This Question Is About

This question relates to summarise this assignment and requires a structured academic response.

How to Approach This Question

Focus on explaining concepts clearly and supporting them with examples.

Key Explanation

This topic involves summarise this assignment. A strong answer should include explanation, application, and examples.

Original Question

SUMMARISE THIS ASSIGNMENT AND ICLUDE NECESSARY POINT “CC Chief Complaint (CC): ” He reports feeling suspicious of those around him and appears both agitated and uneasy” History of Present Illness (HPI): B.A. is a 52-year-old Hispanic male who arrived for a psychiatric evaluation with his son. His medical history shows ongoing management for schizophrenia and generalized anxiety disorder (GAD). Roughly one month after his release from a psychiatric hospital, he began to relapse, displaying moderate aggression, delusional thinking, and psychotic symptoms, which led to his readmission. He became increasingly anxious, convinced that the FBI was watching him. His mental condition declined sharply after the passing of his wife. Although he didn’t begin taking his prescribed medications until a week after being discharged, his prior use of Abilify Maintena monthly injections had kept his schizophrenia symptoms stable. Despite initial signs of improvement post-discharge, his son noted B.A. often voiced concerns about being observed. His mental state eventually regressed. During his assessment, he avoided direct eye contact, which might have reflected mistrust or paranoia toward the clinician. B.A. identifies the loss of his wife as the main cause of his emotional turmoil. There is no documented history of suicidal ideation, delusional behavior, or aggression in the past. He was originally diagnosed with GAD, but antipsychotics were introduced when he began having auditory hallucinations and other mental symptoms that earlier treatments didn’t alleviate. Eighteen months into treatment, B.A. suddenly discontinued his medication due to bothersome side effects such as weight gain and increased appetite. His son, who acts as his main support system, oversees both his medical care and daily needs. It is possible that B.A.’s mental health issues influenced his early retirement from plumbing work. Substance Use History: The patient reports no history of using cigarettes, alcohol, marijuana, or other illegal drugs. Medical History: He has been diagnosed with high blood pressure and has a history of peptic ulcers. He also has seasonal allergies during winter Current Medications: Haloperidol Decanoate, 100 mg/ml, intramuscular injection administered once a month Buspirone, 10 mg, taken orally once per day Omeprazole, 20 mg, taken orally daily Lisinopril, 10 mg, taken orally daily Atorvastatin, 20 mg, taken orally daily Allergies: He is allergic to sulphur through severe itching and redness of the eyes. Reproductive History: Since the death of his wife, the patient has not engaged in any sexual activity for the past two years. Review of Systems (ROS) General The patient reports stable weight, consistent energy, and no recent changes in general health. Sleep is restful and uninterrupted. Physical appearance indicates appropriate nutritional status and good personal hygiene. The patient is alert, oriented, and communicates clearly without distress. Head, Eyes, Ears, Nose, and Throat (HEENT): The patient denies vision problems, eye pain, or visual disturbances. Hearing is normal with no complaints of ear discomfort. There are no symptoms of nasal blockage or sore throat. Examination reveals no abnormalities such as redness, drainage, or swallowing difficulties. Skin: The patient’s skin is healthy in appearance, with normal tone and texture. There are no rashes, lesions, dryness, or areas of irritation noted upon inspection. Cardiovascular: The patient denies chest pain, palpitations, dizziness, or swelling in the extremities. Cardiac assessment is normal with regular heart sounds and no audible murmurs. Peripheral pulses are intact and symmetrical. Respiratory: No respiratory symptoms are reported, including cough, shortness of breath, or wheezing. Auscultation of the lungs shows clear breath sounds bilaterally with no signs of respiratory distress. Gastrointestinal: The patient reports no abdominal discomfort, nausea, vomiting, or changes in appetite. Bowel patterns are regular with no reports of constipation or diarrhea. Genitourinary: Urinary function is normal with no complaints of urgency, frequency, pain, or incontinence. There are no issues related to sexual health. Neurological: The patient does not experience headaches, lightheadedness, weakness, or numbness. Neurologic examination reveals no deficits in coordination, balance, or motor control. No seizure activity or tremors are reported. Musculoskeletal: No joint or muscle pain, stiffness, or swelling is present. The patient demonstrates full mobility and a normal range of motion without discomfort. Hematologic: There is no history of easy bruising, excessive bleeding, or symptoms suggestive of anemia or clotting abnormalities. Healing appears normal. Lymphatic: There are no complaints or findings of swollen or painful lymph nodes. The lymphatic system appears normal on physical exam. Endocrine: The patient reports no symptoms of excessive thirst, abnormal appetite, or changes in urination. There are no signs of intolerance to temperature extremes, and there is no indication of thyroid or adrenal dysfunction. Objective Findings Vital Signs: Blood Pressure: 151/82 mmHg Temperature: 98.7°F Heart Rate: 84 bpm Oxygen Saturation: 100% Height: 5 feet 6 inches Weight: 213 pounds BMI: 29.4 (classified as overweight) Diagnostic Results: Electrocardiogram (EKG): Within normal limits GAD-7 Score: 19 out of 21, indicating severe anxiety symptoms Assessment: Mental Status Evaluation The patient is a 52-year-old Hispanic male, accompanied by his son, presenting to the emergency department for a psychiatric assessment. Initially sociable in the waiting area, he became reserved and withdrawn once in the exam room. Notable anxiety and agitation were observed, which improved with supportive and individualized interaction. He was dressed appropriately for the weather and showed no signs of motor dysfunction. Speech was normal in tone, pace, and rhythm. Although the patient exhibited distractibility and rapid thought patterns, he expressed his concerns coherently. Externally, he appeared calm, yet internally reported significant anxiety and emotional unease. He denied suicidal ideation, hallucinations, or intent to harm others. The patient expressed irrational fears about inadvertently poisoning his child, accompanied by paranoid ideation and delusional thinking centered on medication being used as a form of punishment. Despite these distorted beliefs, he showed no cognitive deficits or physical signs of deterioration. He was alert throughout, with good memory recall, though he admitted difficulty following current events. Additionally, he relies heavily on his son for medication management and appears to struggle with acceptance of his psychiatric diagnosis. Primary diagnoses: DSM-5 Schizophrenia Unspecified (F20.9) DSM-5 Generalized Anxiety Disorder (F41.1) Differential Diagnosis Schizoaffective Disorder-DSM-5 (F33.2) Schizophrenia is a complex mental health condition that often impairs cognitive functioning. Individuals with this disorder may struggle with maintaining focus, regulating mood, and processing thoughts rationally. Key features include delusions, hallucinations, and an altered sense of reality. These symptoms are commonly observed in individuals with schizophrenia. Schizoaffective disorder—a related condition involving both mood and psychotic symptoms—often emerges in individuals under the age of 25 and may include paranoia, sensory hallucinations, and erotomanic beliefs. According to Kring et al. (2018), people with schizophrenia often have overly ambitious expectations regarding career achievement. While genetic factors are believed to contribute to psychotic disorders, the precise etiology remains undetermined. According to Frothingham (2019), caregivers of those with schizophrenia may develop similar behavioral patterns. Additionally, Kring et al. (2018) emphasize the significance of family history, observing that patients with schizophrenia frequently have a parent diagnosed with the condition. Both schizophrenia and schizoaffective disorder can significantly interfere with emotional stability and thought processes. Psychotic NOS DSM-5 (F23.0) The development and diagnosis of psychotic disorders often depend on tracking symptom progression over time. Variability in opinions regarding the origins of these disorders is common among mental health professionals. Smith (2017) underscores the importance of long-term observation in identifying and managing psychotic episodes. In particular, psychotic depression involves intense psychological stress, often accompanied by physical health challenges. A better understanding of genetic risk factors is essential for more precise diagnosis and treatment planning. Bipolar Disorder with Psychotic Features (F31) Bipolar disorder (BD) frequently includes psychotic symptoms (Lundin et al., 2018). The illness is typified by extreme mood shifts, disrupted sleep cycles, and fluctuating energy levels. Growing evidence points to a strong genetic link. According to Chen et al. (2022), individuals with BD may display inconsistent levels of vitality and mood, along with traits such as pupil constriction and signs of depression. These symptoms can impair social functioning, reduce academic and professional opportunities, and jeopardize employment stability. Recent research has also explored the association between circadian rhythm disturbances and cognitive impairments in bipolar disorder. According to Chen et al. (2022), disruptions to the body’s internal clock may correlate with cognitive deficits. The disorder often involves alternating episodes of mania and long-term depressive states, which can persist for extended periods. Reflections: The Patient Outcomes Research Group (PORG) supports the integration of physical therapy into comprehensive mental health care to improve psychological outcomes. A multidisciplinary approach—blending medications, therapy, and skill development—is often most effective for patients pursuing long-term wellness. Nonetheless, Ring et al. (2018) acknowledge the shortcomings of existing pharmacologic treatments for psychosis. Rothschild (2013) suggests that medications such as risperidone, olanzapine, and quetiapine may alleviate symptoms by targeting neurochemical imbalances in the brain. According to Smith (2017) asserts that antidepressants and antipsychotics are foundational in treating psychiatric conditions. Electroconvulsive therapy (ECT) is another well-established treatment, particularly for individuals with severe, treatment-resistant psychotic depression. Cognitive behavioral therapy (CBT) remains a primary modality for helping patients replace maladaptive thoughts with healthier, more productive perspectives. In bipolar disorder, manic phases are often accompanied by irritability, hyperactivity, and sleep issues, although many individuals remain intellectually capable and emotionally expressive. These episodes can significantly disrupt personal relationships and emotional regulation. Treatment goals include achieving mood stabilization and improving behavioral outcomes. Unfortunately, stressful healthcare environments may exacerbate symptoms, making supportive treatment models essential. Psychoeducation, in combination with medication, has been shown to reduce the intensity and frequency of symptoms. It also fosters behavioral change and improves treatment compliance. Healthy routines, such as consistent sleep and regular physical activity, are essential for sustaining recovery. Common co-occurring challenges such as substance use and insomnia may also require targeted intervention. While psychoeducation is promising, its effectiveness in bipolar disorder management still requires validation through randomized controlled trials. Educational sessions typically last six weeks and are open to participants seeking support. Case Formulation and Treatment Plan: Upon completing a thorough evaluation, the patient may benefit from pharmacological intervention to address symptoms of anxiety and depression. However, before starting medication, clinicians should consider psychotherapy options including cognitive retraining, individual counseling, and behavioral therapy. A multimodal treatment plan that combines medication with evidence-based psychotherapeutic methods is often most effective. Healthy People 2030 identifies barriers such as high costs, stigma, and limited access as major obstacles to mental health care, especially for individuals diagnosed with Generalized Anxiety Disorder (F41.1) and Schizophrenia, Unspecified (F20.9). These limitations increase the likelihood of symptom exacerbation and hospital readmission. Overcoming such challenges is essential to improving diagnosis, treatment access, and long-term outcomes. Psychotropic Medications Haloperidol decanoate 100 mg intramuscularly every month or as needed Haloperidol 10 mg orally Buspirone 10 mg orally Contemporary studies emphasize the importance of evaluating the comparative success of various treatment strategies. Effective care plans should integrate psychotherapy, CBT, and structured counseling. Additionally, patients and healthcare professionals must be equipped to navigate complex legal and systemic challenges in the mental health sector.”

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."